These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3263232

  • 1. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R, McKillop JH, Pearson C, Burnett AK, Gunn I, McNicol AM, Thomson JA.
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [Abstract] [Full Text] [Related]

  • 2. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M, Hussain M, Cundy T, Vergani D.
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [Abstract] [Full Text] [Related]

  • 3. Carbimazole and the autoimmune response in Graves' disease.
    McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R.
    N Engl J Med; 1980 Aug 07; 303(6):302-7. PubMed ID: 6247656
    [Abstract] [Full Text] [Related]

  • 4. Differential immunosuppressive action of carbimazole and propylthiouracil.
    Wilson R, McKillop JH, Pearson C, Burnett AK, Thomson JA.
    Clin Exp Immunol; 1988 Aug 07; 73(2):312-5. PubMed ID: 3263234
    [Abstract] [Full Text] [Related]

  • 5. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N, Inoue K, Mori R.
    J Clin Lab Immunol; 1983 Feb 07; 10(2):91-5. PubMed ID: 6221106
    [Abstract] [Full Text] [Related]

  • 6. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov 07; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 7. The effect of pre-operative potassium iodide therapy on antibody production.
    Wilson R, McKillop JH, Thomson JA.
    Acta Endocrinol (Copenh); 1990 Nov 07; 123(5):531-4. PubMed ID: 1979466
    [Abstract] [Full Text] [Related]

  • 8. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R, Vogg M, Swillens S, Usadel KH.
    J Clin Endocrinol Metab; 1993 Oct 07; 77(4):939-43. PubMed ID: 8408468
    [Abstract] [Full Text] [Related]

  • 9. Graves' disease: thyroid function and immunologic activity.
    Gossage AA, Crawley JC, Copping S, Hinge D, Himsworth RL.
    J Nucl Med; 1982 Nov 07; 23(11):973-7. PubMed ID: 6290623
    [Abstract] [Full Text] [Related]

  • 10. [Surgical treatment of Basedow's disease. I--Traditions and new methods in preparation for thyroidectomy: use of dexamethasone].
    Houlbert D, Wassef M, Lajeunie E, Dahan R, Tran ba Huy P, Caporal R, Segrestaa JM.
    Ann Otolaryngol Chir Cervicofac; 1984 Nov 07; 101(7):509-14. PubMed ID: 6548887
    [Abstract] [Full Text] [Related]

  • 11. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P, Harrison LC.
    J Clin Invest; 1984 Sep 07; 74(3):1090-7. PubMed ID: 6088581
    [Abstract] [Full Text] [Related]

  • 12. Studies of autoimmunity in Graves' disease before and after treatment with carbimazole.
    Zosin I, Arcan P, Lungu G, Cotoi A, Opreanu R.
    Endocrinologie; 1988 Sep 07; 26(1):49-53. PubMed ID: 3260398
    [Abstract] [Full Text] [Related]

  • 13. Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves' disease: thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal.
    Guilhem I, Massart C, Poirier JY, Maugendre D.
    Thyroid; 2006 Oct 07; 16(10):1041-5. PubMed ID: 17042691
    [Abstract] [Full Text] [Related]

  • 14. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.
    Madec AM, Allannic H, Genetet N, Gueguen M, Genetet G, Fauchet R, Stefanutti A, Orgiazzi J.
    J Clin Endocrinol Metab; 1986 Jan 07; 62(1):117-21. PubMed ID: 3484386
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole].
    Duprey J, Izembart M, Vallée G, Goupil M.
    Ann Med Interne (Paris); 1986 Jan 07; 137(7):555-8. PubMed ID: 3813296
    [Abstract] [Full Text] [Related]

  • 16. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
    Paunković N, Paunković D.
    Med Pregl; 1995 Jan 07; 48(1-2):10-4. PubMed ID: 8657049
    [Abstract] [Full Text] [Related]

  • 17. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
    Wilson R, McKillop JH, Pearson DW, Cuthbert GF, Thomson JA.
    J Nucl Med; 1985 Sep 07; 26(9):1024-8. PubMed ID: 2863338
    [Abstract] [Full Text] [Related]

  • 18. B- and T-lymphocytes in toxic diffuse goitre.
    Sköldstam L, Anderberg B, Norrby K.
    Clin Exp Immunol; 1978 Mar 07; 31(3):524-5. PubMed ID: 350461
    [Abstract] [Full Text] [Related]

  • 19. Graves' disease: xenotransplantation model (athymic nude mice).
    Rippegather K, Schumm-Draeger PM, Usadel KH.
    Exp Clin Endocrinol Diabetes; 1996 Mar 07; 104 Suppl 3():34-6; discussion 36-7. PubMed ID: 8986419
    [No Abstract] [Full Text] [Related]

  • 20. Clinical relevance of immunological markers in Graves' disease.
    Mann K, Saller B, Hörmann R.
    Exp Clin Endocrinol; 1991 May 07; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.